Toxicokinetic Triage for Environmental Chemicals.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Toxicological Sciences

• Publication date

  2015-09-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/toxsci/kfv118PMID 26085347PMCID PMC4560038
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation of Bayesian prediction models for OATP-mediated drug-drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3.

  2015cited by this paper
• High throughput heuristics for prioritizing human exposure to environmental chemicals.

  2014cited by this paper
• Evaluation of simple in vitro to in vivo extrapolation approaches for environmental compounds.

  2014cited by this paper
• Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing.

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Human Intestinal Transporter Database: QSAR Modeling and Virtual Profiling of Drug Uptake, Efflux and Interactions

  2013influential reference
• Evaluation of an alternative in vitro test battery for detecting reproductive toxicants.

  2013cited by this paper
• High-throughput models for exposure-based chemical prioritization in the ExpoCast project.

  2013cited by this paper
• Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework

  2013cited by this paper
• Relative impact of incorporating pharmacokinetics on predicting in vivo hazard and mode of action from high-throughput in vitro toxicity assays.

  2013cited by this paper
• The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans.

  2012cited by this paper
• Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.

  2012cited by this paper
• Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach

  2012cited by this paper
• A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes.

  2012cited by this paper
• Classification and regression trees

  2012cited by this paper
• Screening of chemicals for human bioaccumulative potential with a physiologically based toxicokinetic model

  2011cited by this paper
• Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment.

  2011influential reference
• Capacities of membrane lipids to accumulate neutral organic chemicals.

  2011cited by this paper
• Intrinsic Human Elimination Half-Lives of Polychlorinated Biphenyls Derived from the Temporal Evolution of Cross-Sectional Biomonitoring Data from the United Kingdom

  2010cited by this paper
• Chembench: a cheminformatics workbench

  2010cited by this paper
• Toxicity Testing in the 21st Century: A Vision and a Strategy

  2010cited by this paper
• Applicability of Generic Assays Based on Liquid Chromatography–Electrospray Mass Spectrometry to Study in vitro Metabolism of 55 Structurally Diverse Compounds

  2010cited by this paper
• National Health and Nutrition Examination Survey

  2010cited by this paper
• Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.

  2010cited by this paper
• Membrane transporters in drug development

  2010cited by this paper
• Confidence Assessment of the Simcyp Time-Based Approach and a Static Mathematical Model in Predicting Clinical Drug-Drug Interactions for Mechanism-Based CYP3A Inhibitors

  2010cited by this paper
• The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

  2009cited by this paper
• In Vitro Screening of Environmental Chemicals for Targeted Testing Prioritization: The ToxCast Project

  2009cited by this paper
• The Simcyp® Population-based ADME Simulator

  2009influential reference
• Prediction of Modified Release Pharmacokinetics and Pharmacodynamics from In Vitro, Immediate Release, and Intravenous Data

  2009cited by this paper
• The Simcyp population-based ADME simulator.

  2009influential reference
• Hepatocellular Binding of Drugs: Correction for Unbound Fraction in Hepatocyte Incubations Using Microsomal Binding or Drug Lipophilicity Data

  2008cited by this paper
• Empirical characterization of random forest variable importance measures

  2008cited by this paper
• Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding.

  2008cited by this paper
• General approach for the calculation of tissue to plasma partition coefficients.

  2008cited by this paper
• Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds

  2008cited by this paper
• The Toxicity Data Landscape for Environmental Chemicals

  2008cited by this paper
• Corrigendum to: ''General approach for the calculation of tissue to plasma partition coefficients" (Toxicology in Vitro 22 (2008) 457-467)

  2008cited by this paper
• Classification and Regression by randomForest

  2007cited by this paper
• The National Health and Nutrition Examination Survey

  2006cited by this paper
• Future of toxicology--predictive toxicology: An expanded view of "chemical toxicity".

  2006cited by this paper
• Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes

  2004cited by this paper
• Lead- and drug-like compounds: the rule-of-five revolution.

  2004cited by this paper
• EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE

  2004cited by this paper
• The SLC16 gene family—from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond

  2004cited by this paper
• Drug transport proteins in the liver.

  2003influential reference
• Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.

  2003cited by this paper
• The Chemistry Development Kit (CDK): An Open-Source Java Library for Chemo-and Bioinformatics

  2003cited by this paper
• Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes.

  2002cited by this paper
• Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.

  2002cited by this paper
• Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method.

  2002cited by this paper
• Random Forests

  2001influential reference
• Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

  1999cited by this paper
• A RIGOROUS TEST FOR SPARC'S CHEMICAL REACTIVITY MODELS : ESTIMATION OF MORE THAN 4300 IONIZATION PKAS

  1995cited by this paper
• Physiological Parameters in Laboratory Animals and Humans

  1993cited by this paper
• SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules

  1988cited by this paper
• Toxicity Testing. Strategies to Determine Needs and Priorities: U.S. National Toxicology Program. 382 pp. Washington, DC: National Academy Press (1984)

  1987cited by this paper
• Toxicity Testing: Strategies to Determine Needs and Priorities

  1984cited by this paper
• Commentary: a physiological approach to hepatic drug clearance.

  1975cited by this paper
• A physiological approach to hepatic drug clearance

  1975cited by this paper

• Comparative Analysis of Caco-2 Cells and Human Jejunal and Duodenal Enteroid-Derived Cells in Gel- and Membrane-Based Barrier Models of Intestinal Permeability.

  2025cites this paper
• Scientific Opinion on the application of physiologically based kinetic (PBK) modelling for the quantitative in vitro to in vivo extrapolation (QIVIVE) of developmental neurotoxicity in vitro battery (DNT IVB) data for pesticide active substances

  2025cites this paper
• Machine learning to predict food effects during drug development: a comprehensive review

  2025cites this paper
• Evaluations of Sex Differences in Dosimetry in Rats Following Perfluorohexanesulfonamide (PFHxSA) Oral Exposure

  2025cites this paper
• Comparison of physiologically based pharmacokinetic modeling platforms for developmental neurotoxicity in vitro to in vivo extrapolation.

  2025cites this paper
• Systematic Evaluation of In Vitro Intestinal Permeability Measurements Across Diverse Chemicals: Insights for Advancing New Approach Methods for Chemical Risk Assessment.

  2025cites this paper
• Refining High-Throughput In Vitro-In vivo Extrapolation Modeling through Incorporation of Intestinal Toxicokinetics.

  2025cites this paper
• Applying New Approach Methods for Toxicokinetics for Chemical Risk Assessment.

  2025cites this paper
• Prediction of Internal Exposures after Virtual Oral Doses of Disparate Chemicals in Rats and Humans Using Simplified Physiologically Based Pharmacokinetic Models with In Silico-Generated Input Parameters.

  2025cites this paper
• Insights derived from testing a library of per- and polyfluoroalkyl substances (PFAS) in a battery of new approach methods (NAMs)

  2025cites this paper
• Enabling transparent toxicokinetic modeling for public health risk assessment

  2025influential citation
• Potential Systemic Availability Classification of Chemicals for Safety Assessment

  2025cites this paper
• Exploring the use of Artificial Intelligence (AI) for extracting and integrating data obtained through New Approach Methodologies (NAMs) for chemical risk assessment

  2024cites this paper
• Generic kinetic and kinetic‐dynamic modelling in human subgroups of the population and animal species to support transparency in food and feed safety: Case studies

  2024cites this paper
• The Environmental Neuroactive Chemicals List of Prioritized Substances for Human Biomonitoring and Neurotoxicity Testing: A Database and High-Throughput Toxicokinetics Approach.

  2024cites this paper
• In Vitro Hepatic Clearance Evaluations of Per- and Polyfluoroalkyl Substances (PFAS) across Multiple Structural Categories

  2024cites this paper
• A physiologically based toxicokinetic model for microplastics and nanoplastics in mice after oral exposure and its implications for human dietary exposure assessment.

  2024cites this paper
• The Use of Toxicokinetic Information for Setting Concentrations of In Vitro Toxicity Tests and for Interpreting Their Results: A Proposed Workflow

  2024cites this paper
• Evaluating scientific confidence in the concordance of in vitro and in vivo protective points of departure.

  2024cites this paper
• Quantitative in vitro to in vivo extrapolation for human toxicology and drug development

  2024cites this paper
• HExpPredict: In Vivo Exposure Prediction of Human Blood Exposome Using a Random Forest Model and Its Application in Chemical Risk Prioritization

  2023cites this paper
• TKPlate 1.0: An Open‐access platform for toxicokinetic and toxicodynamic modelling of chemicals to implement new approach methodologies in chemical risk assessment

  2023cites this paper
• In vitro to in vivo extrapolation for predicting human equivalent dose of phenolic endocrine disrupting chemicals: PBTK model development, biological pathways, outcomes and performance.

  2023cites this paper
• Explore the Dosimetric Relationship between the Intake of Chemical Contaminants and Their Occurrence in Blood and Urine

  2023cites this paper
• Plasma Protein Binding Evaluations of Per- and Polyfluoroalkyl Substances for Category-Based Toxicokinetic Assessment.

  2023cites this paper
• Development of physiologically-based gut absorption model for probabilistic prediction of environmental chemical bioavailability.

  2023cites this paper
• A Machine Learning Model to Estimate Toxicokinetic Half-Lives of Per- and Polyfluoro-Alkyl Substances (PFAS) in Multiple Species

  2023cites this paper
• Prioritization of chemicals in food for risk assessment by integrating exposure estimates and new approach methodologies: A next generation risk assessment case study

  2022cites this paper
• Quantitative in vitro to in vivo extrapolation of genotoxicity data provides protective estimates of in vivo dose

  2022cites this paper
• Prioritization of mixtures of neurotoxic chemicals for biomonitoring using high-throughput toxicokinetics and mixture toxicity modeling.

  2022cites this paper
• Forward and reverse dosimetry for aniline and 2,6-dimethylaniline in humans extrapolated from humanized-liver mouse data using simplified physiologically based pharmacokinetic models.

  2022cites this paper
• Exposure Forecasting – ExpoCast – for Data-Poor Chemicals in Commerce and the Environment

  2022cites this paper
• Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate.

  2022cites this paper
• In silico model-based exploration of the applicability of parallel artificial membrane permeability assay (PAMPA) to screen chemicals of environmental concern.

  2022cites this paper
• Estimating provisional margins of exposure for data-poor chemicals using high-throughput computational methods

  2022cites this paper
• Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.

  2022cites this paper
• Evaluation of a Rapid, Generic Human Gestational Dose Model.

  2022cites this paper
• Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment

  2022influential citation
• Advances in computational methods along the exposure to toxicological response paradigm.

  2022cites this paper
• Development of the InTelligence And Machine LEarning (TAME) Toolkit for Introductory Data Science, Chemical-Biological Analyses, Predictive Modeling, and Database Mining for Environmental Health Research

  2022cites this paper
• Beyond Pharmaceuticals: Fit-for-Purpose New Approach Methodologies for Environmental Cardiotoxicity Testing

  2022cites this paper
• IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making

  2022cites this paper
• PBK modelling of topical application and characterisation of the uncertainty of Cmax estimate: A case study approach.

  2022cites this paper
• Use of computational toxicology tools to predict in vivo endpoints associated with Mode of Action and the endocannabinoid system: A case study with chlorpyrifos, chlorpyrifos-oxon and Δ9Tetrahydrocannabinol

  2022cites this paper
• Probabilistic Risk Assessment – The Keystone for the Future of Toxicology

  2022cites this paper
• Bayesian inference of chemical exposures from NHANES urine biomonitoring data

  2022cites this paper
• Risk-Based Chemical Ranking and Generating a Prioritized Human Exposome Database

  2021cites this paper
• Implementing In Vitro Bioactivity Data to Modernize Priority Setting of Chemical Inventories

  2021cites this paper
• Hepatotoxicological potential of P-toluic acid in humanised-liver mice investigated using simplified physiologically based pharmacokinetic models

  2021cites this paper
• Incorporating Population Variability in Toxicokinetic Modeling for Risk-Based Prioritization

  2021cites this paper
• Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors.

  2021cites this paper
• Prediction of Hepatic Drug Clearance with a Human Microfluidic Four-Cell Liver Acinus MicroPhysiology System.

  2021cites this paper
• In Silico Prediction of Input Parameters for Simplified Physiologically Based Pharmacokinetic Models for Estimating Plasma, Liver, and Kidney Exposures in Rats after Oral Doses of 246 Disparate Chemicals.

  2021cites this paper
• Estimating Hepatotoxic Doses Using High-Content Imaging in Primary Hepatocytes.

  2021cites this paper
• An integrated exposure and pharmacokinetic modeling framework for assessing population-scale risks of phthalates and their substitutes.

  2021cites this paper
• Quantitative in Vitro-to-in Vivo Extrapolation for Mixtures: A Case Study of Superfund Priority List Pesticides.

  2021cites this paper
• High-throughput PBTK models for in vitro to in vivo extrapolation

  2021influential citation
• Sourcing data on chemical properties and hazard data from the US-EPA CompTox Chemicals Dashboard: A practical guide for human risk assessment

  2021influential citation
• Rapid Hazard Characterization of Environmental Chemicals Using a Compendium of Human Cell Lines from Different Organs

  2020cites this paper
• Database of pharmacokinetic time-series data and parameters for 144 environmental chemicals

  2020cites this paper
• A case study with triazole fungicides to explore practical application of next generation hazard assessment methods for human health.

  2020cites this paper
• High-throughput screening tools facilitate calculation of a combined exposure-bioactivity index for chemicals with endocrine activity

  2020cites this paper
• Population Life-course exposure to health effects model (PLETHEM): An R package for PBPK modeling

  2020cites this paper
• Database of pharmacokinetic time-series data and parameters for 144 environmental chemicals

  2020cites this paper
• The Exposome and the Public:Toxicity and Exposure Models

  2020cites this paper
• Application of structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic model development and evaluation.

  2020cites this paper
• Physiologically Based Pharmacokinetic Models Predicting Renal and Hepatic Concentrations of Industrial Chemicals after Virtual Oral Doses in Rats.

  2020cites this paper
• In vitro-in silico-based probabilistic risk assessment of combined exposure to bisphenol A and its analogues by integrating ToxCast high-throughput in vitro assays with in vitro to in vivo extrapolation (IVIVE) via physiologically based pharmacokinetic (PBPK) modeling.

  2020cites this paper
• Physiologically based pharmacokinetic models to support modernized chemical safety assessment

  2020cites this paper
• Use of computational toxicology (CompTox) tools to predict in vivo toxicity for risk assessment.

  2020cites this paper
• Selecting a minimal set of androgen receptor assays for screening chemicals

  2020cites this paper
• Evaluating consumer exposure to disinfecting chemicals against coronavirus disease 2019 (COVID-19) and associated health risks

  2020cites this paper
• Recent Advances in Probabilistic Dose–Response Assessment to Inform Risk‐Based Decision Making

  2020cites this paper
• Using Chemical Structure Information to Develop Predictive Models for In Vitro Toxicokinetic Parameters to Inform High-throughput Risk-assessment.

  2020cites this paper
• Metabolic Profiles of Tetrabromobisphenol A in Humans Extrapolated from Humanized-Liver Mouse Data Using a Simplified Physiologically Based Pharmacokinetic Model.

  2020cites this paper
• Plasma, liver, and kidney exposures in rats after oral doses of industrial chemicals predicted using physiologically based pharmacokinetic models: A case study of perfluorooctane sulfonic acid.

  2020cites this paper
• Different Hepatic Concentrations of Bromobenzene, 1,2-Dibromobenzene, and 1,4-Dibromobenzene in Humanized-Liver Mice Predicted Using Simplified Physiologically Based Pharmacokinetic Models as Putative Markers of Toxicological Potential.

  2020cites this paper
• Exposure-based Chemical Priority Setting in the 21st Century

  2020cites this paper
• Physiologically based kinetic models for farm animals: Critical review of published models and future perspectives for their use in chemical risk assessment

  2019cites this paper
• Estimating uncertainty in the context of new approach methodologies for potential use in chemical safety evaluation

  2019cites this paper
• Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene

  2019cites this paper
• Recent advances in probabilistic dose-response assessment to inform socioeconomic benefits analysis

  2019cites this paper
• Screening for neurotoxic potential of 15 flame retardants using freshwater planarians

  2019cites this paper
• The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.

  2019cites this paper
• Toxicology in Vitro Physiologically based kinetic models for farm animals: Critical review of published models and future perspectives for their use in chemical risk assessment

  2019cites this paper
• Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop

  2019cites this paper
• Toxicity testing in the 21st century: progress in the past decade and future perspectives

  2019cites this paper
• Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization.

  2019cites this paper
• Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.

  2019cites this paper
• A framework for application of quantitative property-property relationships (QPPRs) in physiologically based pharmacokinetic (PBPK) models for high-throughput prediction of internal dose of inhaled organic chemicals.

  2019cites this paper
• UNDERSTANDING CONDITIONAL MODES OF ACTIONS IN CHEMICAL-INDUCED TOXICITY USING RULE MODELS

  2019cites this paper
• New Approach Methodologies for Exposure Science.

  2019cites this paper
• Identification of potential endocrine disrupting chemicals using gene expression biomarkers.

  2019cites this paper
• Extrapolation of Hepatic Concentrations of Industrial Chemicals Using Pharmacokinetic Models to Predict Hepatotoxicity

  2019cites this paper
• Comparative analysis of Rapid Equilibrium Dialysis (RED) and solid phase micro-extraction (SPME) methods for In Vitro-In Vivo extrapolation of environmental chemicals.

  2019cites this paper
• Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions

  2019cites this paper
• Leveraging human genetic and adverse outcome pathway (AOP) data to inform susceptibility in human health risk assessment

  2018cites this paper
• The Impact of Novel Assessment Methodologies in Toxicology on Green Chemistry and Chemical Alternatives

  2018cites this paper
• Conditional Toxicity Value (CTV) Predictor: An In Silico Approach for Generating Quantitative Risk Estimates for Chemicals

  2018cites this paper
• In Vitro Methods for Pharmacokinetics: What Works and What Doesn’t for Extrapolation to In Vivo Exposures?

  2018cites this paper